BSECompany Update7 Oct 2026 · 7 Oct 2026, 06:47 pm

CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018 FOR THE QUARTER ENDED 30.09.2026

Beryl Drugs Ltd · 524606

✦ AI SummaryRegulatory

Beryl Drugs Ltd has filed reports for the quarter ended 30.09.2026, including a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and a non-applicability certificate under Regulation 57(5).

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Beryl Drugs Ltd - 524606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

28e3365f-85ce-4c80-8e62-279e8240fc7d.pdf

pdf

Download →
View document text
BERYL. orves tures TR ee lg .d :. (O 0f 7f 3. 1: )2 9 2, 1N 7e 6e 7r g Ear -, a" iM la y a bn ek yW la dt re ur sP 2a 5rk yR ao ha od o" ., oBi mc h |o l Ci H Na p :s i L, 2I 4N 2D 3O MR PE 1- 94 95 32 P0 L1 C6 ( 7M 8.P 4. 0) INDIA Date: 06" October, 2026 The DCS- Listing, The Bombay Stock Exchange Limited, Phiroze JeeJeebhoy Towers, Dalal Street, Mumbai — 400 001 Script Code: 524606 Sub.: Filing of Reports for the quarter ended on 30.09.2026 Dear Sir, With reference to various conditions stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by the listed Companies, we are enclosing herewith the following documents for your record, relating to quarter ended on 30th September, 2026 1. Regulation 74 (5) - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30" September, 2026 2. Regulation 57(5)- Non- Applicability Certificate Under Regulation 57(5) for the quarter ended 30 September, 2026 For Beryl Drugs Limited_ Sudhir Sethi Chairman& Di DIN: 00090172 adroit ‘CORPORATE SERVICES PYT LTD. 03 October 2026 BERYL DRUGS LIMITED 29, NEER NAGAR MAYANK WATER PARK ROAD BICHOLI (M.P.) INDORE 452016 Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and participants) Regulations, 2018. Dear Sir/Madam, In reference to the above captioned regulation,we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th September,2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been Mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as regist- ered owner within 15 days. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For Adroit Corporate Services Pvt. Ltd. Authorized Signatory. 19-20 Jaferbhoy Industrial Estate, Makwana Road, Marol Naka, Andheri (E), Mumbai, Maharashtra, 400 059. Tel: 022 - 4227 0400, 2859 4060. Fax: 2850 3748. Email: info@adroitcorporate.com CIN: U67190MH1994PTC079160